Cargando…

Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure

BACKGROUND: Mycobacterium tuberculosis genotyping has been crucial to determining the distribution and impact of different families on disease clinical presentation. The aim of the study was to evaluate the associations among sociodemographic and clinical characteristics and M. tuberculosis lineages...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordaz-Vázquez, Anabel, Torres-González, Pedro, Ferreyra-Reyes, Leticia, Canizales-Quintero, Sergio, Delgado-Sánchez, Guadalupe, García-García, Lourdes, Ponce-De-León, Alfredo, Sifuentes-Osornio, José, Bobadilla-Del-Valle, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012486/
https://www.ncbi.nlm.nih.gov/pubmed/36918814
http://dx.doi.org/10.1186/s12879-023-08055-9
_version_ 1784906614397992960
author Ordaz-Vázquez, Anabel
Torres-González, Pedro
Ferreyra-Reyes, Leticia
Canizales-Quintero, Sergio
Delgado-Sánchez, Guadalupe
García-García, Lourdes
Ponce-De-León, Alfredo
Sifuentes-Osornio, José
Bobadilla-Del-Valle, Miriam
author_facet Ordaz-Vázquez, Anabel
Torres-González, Pedro
Ferreyra-Reyes, Leticia
Canizales-Quintero, Sergio
Delgado-Sánchez, Guadalupe
García-García, Lourdes
Ponce-De-León, Alfredo
Sifuentes-Osornio, José
Bobadilla-Del-Valle, Miriam
author_sort Ordaz-Vázquez, Anabel
collection PubMed
description BACKGROUND: Mycobacterium tuberculosis genotyping has been crucial to determining the distribution and impact of different families on disease clinical presentation. The aim of the study was to evaluate the associations among sociodemographic and clinical characteristics and M. tuberculosis lineages from patients with pulmonary tuberculosis in Orizaba, Veracruz, Mexico. METHODS: We analyzed data from 755 patients whose isolates were typified by 24-loci mycobacterial interspersed repetitive unit–variable number of tandem repeats (MIRU–VNTR). The associations among patient characteristics and sublineages found were evaluated using logistic regression analysis. RESULTS: Among M. tuberculosis isolates, 730/755 (96.6%) were assigned to eight sublineages of lineage 4 (Euro-American). Alcohol consumption (adjusted odds ratio [aOR] 1.528, 95% confidence interval (CI) 1.041–2.243; p = 0.030), diabetes mellitus type 2 (aOR 1.625, 95% CI 1.130–2.337; p = 0.009), sputum smear positivity grade (3+) (aOR 2.198, 95% CI 1.524–3.168; p < 0.001) and LAM sublineage isolates (aOR 1.023, 95% CI 1.023–2.333; p = 0.039) were associated with the presence of cavitations. Resistance to at least one drug (aOR 25.763, 95% CI 7.096–93.543; p < 0.001) and having isolates other than Haarlem and LAM sublineages (aOR 6.740, 95% CI 1.704–26.661; p = 0.007) were associated with treatment failure. In a second model, multidrug resistance was associated with treatment failure (aOR 31.497, 95% CI 5.119–193.815; p < 0.001). Having more than 6 years of formal education was not associated with treatment failure. CONCLUSIONS: Knowing M. tuberculosis genetic diversity plays an essential role in disease development and outcomes, and could have important implications for guiding treatment and improving tuberculosis control. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08055-9.
format Online
Article
Text
id pubmed-10012486
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100124862023-03-15 Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure Ordaz-Vázquez, Anabel Torres-González, Pedro Ferreyra-Reyes, Leticia Canizales-Quintero, Sergio Delgado-Sánchez, Guadalupe García-García, Lourdes Ponce-De-León, Alfredo Sifuentes-Osornio, José Bobadilla-Del-Valle, Miriam BMC Infect Dis Research BACKGROUND: Mycobacterium tuberculosis genotyping has been crucial to determining the distribution and impact of different families on disease clinical presentation. The aim of the study was to evaluate the associations among sociodemographic and clinical characteristics and M. tuberculosis lineages from patients with pulmonary tuberculosis in Orizaba, Veracruz, Mexico. METHODS: We analyzed data from 755 patients whose isolates were typified by 24-loci mycobacterial interspersed repetitive unit–variable number of tandem repeats (MIRU–VNTR). The associations among patient characteristics and sublineages found were evaluated using logistic regression analysis. RESULTS: Among M. tuberculosis isolates, 730/755 (96.6%) were assigned to eight sublineages of lineage 4 (Euro-American). Alcohol consumption (adjusted odds ratio [aOR] 1.528, 95% confidence interval (CI) 1.041–2.243; p = 0.030), diabetes mellitus type 2 (aOR 1.625, 95% CI 1.130–2.337; p = 0.009), sputum smear positivity grade (3+) (aOR 2.198, 95% CI 1.524–3.168; p < 0.001) and LAM sublineage isolates (aOR 1.023, 95% CI 1.023–2.333; p = 0.039) were associated with the presence of cavitations. Resistance to at least one drug (aOR 25.763, 95% CI 7.096–93.543; p < 0.001) and having isolates other than Haarlem and LAM sublineages (aOR 6.740, 95% CI 1.704–26.661; p = 0.007) were associated with treatment failure. In a second model, multidrug resistance was associated with treatment failure (aOR 31.497, 95% CI 5.119–193.815; p < 0.001). Having more than 6 years of formal education was not associated with treatment failure. CONCLUSIONS: Knowing M. tuberculosis genetic diversity plays an essential role in disease development and outcomes, and could have important implications for guiding treatment and improving tuberculosis control. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08055-9. BioMed Central 2023-03-14 /pmc/articles/PMC10012486/ /pubmed/36918814 http://dx.doi.org/10.1186/s12879-023-08055-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ordaz-Vázquez, Anabel
Torres-González, Pedro
Ferreyra-Reyes, Leticia
Canizales-Quintero, Sergio
Delgado-Sánchez, Guadalupe
García-García, Lourdes
Ponce-De-León, Alfredo
Sifuentes-Osornio, José
Bobadilla-Del-Valle, Miriam
Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
title Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
title_full Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
title_fullStr Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
title_full_unstemmed Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
title_short Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
title_sort mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012486/
https://www.ncbi.nlm.nih.gov/pubmed/36918814
http://dx.doi.org/10.1186/s12879-023-08055-9
work_keys_str_mv AT ordazvazquezanabel mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT torresgonzalezpedro mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT ferreyrareyesleticia mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT canizalesquinterosergio mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT delgadosanchezguadalupe mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT garciagarcialourdes mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT poncedeleonalfredo mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT sifuentesosorniojose mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure
AT bobadilladelvallemiriam mycobacteriumtuberculosislineage4associatedwithcavitationsandtreatmentfailure